We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Seneca Foods Class A
SENEA
$1.11B
| $593K | ﹤0.01% |
24,107
+3,285
| +16% | +$93.2K |
|
1302
Interface
TILE
$1.87B
| $593K | ﹤0.01% |
38,739
+455
| +1% | +$7.45K |
|
1303
United Fire Group
UFCS
$1.26B
| $587K | ﹤0.01% |
13,438
+2,784
| +26% | +$139K |
|
1304
Charles River Laboratories
CRL
$10.9B
| $585K | ﹤0.01% |
4,026
-3,163
| -44% | -$416K |
|
1305
Walker & Dunlop
WD
$1.6B
| $580K | ﹤0.01% |
11,387
-940
| -8% | -$47.7K |
|
1306
Curtiss-Wright
CW
$27.5B
| $579K | ﹤0.01% |
5,109
-1,016
| -17% | -$116K |
|
|
CTLT
1307
DELISTED
CATALENT, INC.
CTLT
| $579K | ﹤0.01% |
14,276
-5,325
| -27% | -$208K |
|
|
NPKI
1308
NPK International
NPKI
$1.26B
| $577K | ﹤0.01% |
63,003
-6,566
| -9% | -$56.3K |
|
1309
DXP Enterprises
DXPE
$2.69B
| $576K | ﹤0.01% |
14,803
-4,098
| -22% | -$143K |
|
1310
Belden
BDC
$4.01B
| $575K | ﹤0.01% |
10,706
-3,005
| -22% | -$165K |
|
|
CDK
1311
DELISTED
CDK Global, Inc.
CDK
| $575K | ﹤0.01% |
9,771
-1,515
| -13% | -$82.6K |
|
1312
OGE Energy
OGE
$10.2B
| $574K | ﹤0.01% |
13,319
-158,545
| -92% | -$6.57M |
|
1313
Mativ Holdings
MATV
$438M
| $569K | ﹤0.01% |
14,702
-4,539
| -24% | -$155K |
|
|
VG
1314
DELISTED
Vonage Holdings Corporation
VG
| $568K | ﹤0.01% |
56,587
+1,701
| +3% | +$16.3K |
|
1315
Viavi Solutions
VIAV
$10.6B
| $566K | ﹤0.01% |
45,708
-2,300
| -5% | -$26.9K |
|
1316
Carpenter Technology
CRS
$29.5B
| $565K | ﹤0.01% |
12,327
-1,895
| -13% | -$84.4K |
|
|
PE
1317
DELISTED
PARSLEY ENERGY INC
PE
| $565K | ﹤0.01% |
29,303
-3,500
| -11% | -$64.3K |
|
1318
Ralph Lauren
RL
$22.3B
| $562K | ﹤0.01% |
4,337
-9,391
| -68% | -$1.12M |
|
1319
Alamo Group
ALG
$2.01B
| $561K | ﹤0.01% |
5,610
-965
| -15% | -$87K |
|
1320
Enova International
ENVA
$5.39B
| $560K | ﹤0.01% |
24,535
-4,550
| -16% | -$107K |
|
|
SHOE
1321
Shoe Station Group
SHOE
$390M
| $557K | ﹤0.01% |
32,748
-474
| -1% | -$8.62K |
|
|
NP
1322
DELISTED
Neenah, Inc. Common Stock
NP
| $557K | ﹤0.01% |
8,651
+613
| +8% | +$40.7K |
|
1323
Analog Devices
ADI
$185B
| $555K | ﹤0.01% |
5,271
-4,945
| -48% | -$496K |
|
1324
Gibraltar Industries
ROCK
$1.31B
| $553K | ﹤0.01% |
13,623
-1,857
| -12% | -$70.8K |
|
|
EFII
1325
DELISTED
Electronics for Imaging
EFII
| $550K | ﹤0.01% |
20,436
+837
| +4% | +$22K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.